Latest News

Shenzhen Dobot (SEHK:2432) has reported FY 2025 results that pair rapid top line expansion with ongoing losses, with second half revenue at C¥339.1 million and basic EPS at a loss of C¥0.10. The company has seen first half FY 2025 revenue of C¥153.1 million and a basic EPS loss of C¥0.10, compared with second half FY 2024 revenue of C¥253.2 million and a basic EPS loss of C¥0.10. This sets up a story where strong revenue momentum meets pressure on margins and a clear focus on when...

China International Capital (SEHK:3908) has wrapped up FY 2025 with fourth quarter revenue of C¥10.7b and basic EPS of C¥0.73, set against trailing twelve month revenue of C¥31.1b and EPS of C¥1.88 that came alongside an 81.1% earnings increase and net profit margins moving from 23.9% to 29.1%. Over recent periods, revenue has stepped up from C¥20.9b on a trailing basis in late 2024 to C¥31.1b by the end of 2025. Quarterly EPS has ranged from C¥0.12 in Q3 2024 to C¥0.73 in Q4 2025, indicating...

Homeland Interactive Technology (SEHK:3798) has opened FY 2025 with first half revenue of C¥726.0 million and basic EPS of C¥0.03, following a trailing twelve month result that included C¥1.35 billion of revenue and C¥0.05 in basic EPS. Over recent reporting periods the company has seen revenue move from C¥835.7 million in 1H 2024 to C¥550.4 million in 2H 2024 and C¥726.0 million in 1H 2025. Over the same periods, basic EPS shifted from C¥0.02 to a loss of C¥0.08 and then to C¥0.03. This puts...

Labixiaoxin Snacks Group (SEHK:1262) has opened FY 2025 with first half revenue of C¥516 million and basic EPS of C¥0.01, while trailing twelve month figures show revenue of C¥969.8 million and basic EPS of C¥0.05. This points to a shift from losses reported in 2024. Over recent periods, revenue has moved from C¥493.8 million in 1H 2024 to C¥372.9 million in 2H 2024 and then to C¥516 million in 1H 2025. Over the same spans, EPS has moved from losses of C¥0.33 and C¥0.23 per share in 1H and 2H...

VICI Properties (VICI) has attracted attention after a recent pullback, with the stock showing a 9.6% decline over the past month and a smaller 2.8% decline over the past 3 months. See our latest analysis for VICI Properties. At a share price of $27.32, VICI’s recent 9.6% 1 month share price return decline and 2.8% 3 month share price return decline sit against a 10.6% 1 year total shareholder return decline and a 22.4% 5 year total shareholder return gain. This suggests near term momentum...

LEPU ScienTech Medical Technology (Shanghai) (SEHK:2291) opened FY 2025 with first half revenue of C¥329.7 million and basic EPS of C¥0.52, setting the tone for how its profitability story is evolving. Over the recent periods, the company has seen revenue move from C¥249.1 million in 1H 2024 to C¥222.5 million in 2H 2024 and then to C¥329.7 million in 1H 2025, while basic EPS shifted from C¥0.40 to C¥0.30 and then to C¥0.52, giving investors a clear view of how the top and bottom lines are...

Digital Domain Holdings (SEHK:547) has posted its FY 2025 results with first half revenue of HK$416.5 million and a basic EPS loss of HK$0.0111 per share, while trailing twelve month revenue stood at HK$777.3 million against a net loss of HK$257.3 million. The company has seen revenue move from HK$264.9 million in the first half of 2024 to HK$360.9 million in the second half and then to HK$416.5 million in the first half of 2025, with EPS losses ranging between HK$0.0239 and HK$0.0111 over...

JST Group (SEHK:6687) has reported its FY 2025 first half with revenue of C¥523.6 million and a basic EPS loss of C¥23.09, while trailing twelve month figures show revenue of C¥1.1 billion and a basic EPS loss of C¥7.27. The company has seen revenue move from C¥697.2 million in the second half of 2023 to C¥909.8 million in the second half of 2024 and then to C¥1.0 billion on a trailing basis to the first half of 2025. Over the same periods, basic EPS shifted from a loss of C¥273.07 to a...

If you are wondering whether Guardian Pharmacy Services at US$37.66 is priced for opportunity or already reflecting high expectations, the valuation picture is the key place to focus next. The stock has posted returns of 0.2% over the last 7 days, 12.4% over the last 30 days, 27.5% year to date and 79.2% over the past year. This naturally raises questions about how much of the story is already in the price. Recent news coverage has centered on Guardian Pharmacy Services as a healthcare name...

With the business potentially at an important milestone, we thought we'd take a closer look at Iterum Therapeutics...

Shanghai Biren Technology (SEHK:6082) opened FY 2025 with first half revenue of C¥58.9 million and a basic EPS loss of C¥0.93, against a trailing twelve month revenue base of C¥1.0 billion and a reported net loss of about C¥16.5 billion. Over recent periods, the company has seen revenue move from C¥39.3 million in 1H 2024 to C¥297.5 million in 2H 2024 and then to C¥58.9 million in 1H 2025, while basic EPS stayed in loss-making territory across those halves, so the focus now is squarely on how...

General Motors (NYSE:GM) is temporarily laying off about 1,300 workers and extending downtime at its Factory ZERO electric vehicle plant in Detroit. The company is reducing EV production while increasing output of heavy duty gas powered trucks to address current demand patterns. The changes affect employment, production planning, and GM’s mix between electric and internal combustion vehicles. For you as an investor, this move sits at the crossroads of GM’s long term EV ambitions and its...

Pfizer (PFE) is back in focus after reporting over 70% efficacy in a Phase 3 Lyme disease vaccine trial and positive Phase 3 results for prostate cancer therapy TALZENNA in combination with XTANDI. See our latest analysis for Pfizer. Positive readouts across vaccines and oncology have coincided with a pick up in momentum, with an 11.5% year to date share price return and a 12.8% 90 day share price return helping lift Pfizer to a 1 year total shareholder return of 22.7% despite weaker 3 and 5...

Natural Food International Holding (SEHK:1837) has kicked off FY 2025 with first half revenue of C¥1.1b and basic EPS of C¥0.049, setting the tone for a year that follows a trailing twelve month EPS of C¥0.122. Over recent reporting periods the company has seen revenue move from C¥992.4m in 1H 2024 to C¥1.1b in 1H 2025, while basic EPS has stepped from C¥0.0416 to C¥0.049, giving investors a clearer view of how earnings are tracking through the most recent year on year stretch. With net...

MSCI (NYSE:MSCI) plans to reclassify Greece from Emerging Market to Developed Market status in its equity indexes. The company is also partnering with Syntax Data to expand its ADR index offerings for financial advisers in the US. These changes affect how global capital is allocated to Greek equities and how advisers access international exposure through US listed securities. MSCI is best known for its global equity indexes that many asset managers and ETFs use as benchmarks, so its country...

In late March 2026, an explosion and fire at Valero Energy’s Port Arthur, Texas refinery injured worker Jonathan Jaimes and prompted a lawsuit alleging unsafe conditions and gross negligence. Although most operations at the 435,000-barrel-per-day refinery were restarted within two days, a key diesel hydrotreater remains offline, highlighting ongoing operational and legal risks tied to the incident. Next, we’ll examine how the Port Arthur explosion, ongoing diesel unit outage, and related...

In March 2026, Signet Jewelers reported fourth-quarter sales of US$2,345.1 million and net income of US$250.0 million, alongside a higher full-year profit, while also raising its quarterly dividend to US$0.35 per share and continuing share repurchases. The sharp year-on-year jump in earnings per share, combined with a nearly double-digit dividend increase and ongoing buybacks, underscores management’s confidence in the company’s financial position and cash-generation capacity. We’ll now...

MicroTech Medical (Hangzhou) (SEHK:2235) has opened FY 2025 with first half revenue of C¥245.9 million and a basic EPS loss of C¥0.005444, while trailing twelve month figures show revenue of C¥660.8 million and basic EPS of C¥0.10. Over recent reporting periods, the company has seen revenue move from C¥150.8 million in 1H 2024 to C¥194.8 million in 2H 2024 and then to C¥245.9 million in 1H 2025. Basic EPS has shifted from a loss of C¥0.089602 in 1H 2024 and C¥0.060927 in 2H 2024 to a much...

Invesco (IVZ) is drawing fresh attention after expanding its Invesco QQQ Innovation Suite with the launch of the Invesco QQQ Equal Weight ETF, QEW, which offers equal-weight exposure to Nasdaq-100 companies. See our latest analysis for Invesco. Recent trading reflects mixed momentum, with a 1-day share price return of 4.29% taking Invesco to $24.29. This contrasts with 30-day and year to date share price returns of 7.50% and 9.84% declines, alongside a 1-year total shareholder return of...

Shandong Boan Biotechnology (SEHK:6955) has posted its FY 2025 first half results with total revenue of C¥393.4 million and basic EPS of C¥0.036, while trailing 12 month revenue reached C¥784.8 million on basic EPS of C¥0.01 as the market weighs these figures against a share price of C¥6.85. Over recent reporting periods, the company has seen revenue move from C¥362.9 million in 1H 2024 to C¥363.4 million in 2H 2024 and then to C¥393.4 million in 1H 2025, with basic EPS shifting from C¥0.121...

Beijing Energy International Holding (SEHK:686) has put fresh numbers on the table for FY 2025, with first half revenue of C¥4.1b and basic EPS of C¥0.0787, against trailing 12 month revenue of C¥7.7b and a loss per share of C¥0.0723 that keeps the overall period in the red. Over the recent reporting halves, revenue has stepped up from C¥3.3b with EPS of C¥0.0148 in 1H 2024, to C¥3.7b with EPS of C¥0.0241 in 2H 2024, and then to C¥4.1b with EPS of C¥0.0787 in 1H 2025. Trailing 12 month net...

Samsara Inc. recently announced its 2026 North America Customer Advisory Board, bringing together senior leaders from major logistics, utilities, construction, and industrial organizations to provide operational insights that inform product development. This board has already influenced offerings like Samsara Coach and the Asset Tag XS and is expected to shape further product innovations informed directly by large enterprise customers’ real-world needs. We’ll now examine how this expanded...

In March 2026, Neurocrine Biosciences presented new expert consensus recommendations and fresh INGREZZA (valbenazine) data on older adults with tardive dyskinesia at the PALTC26 conference in Anaheim, highlighting care challenges in long-term care settings. The company underscored INGREZZA’s differentiated clinical profile for seniors, including no required dose titration and a sprinkle formulation, alongside patient-reported improvements in symptoms, quality of life and functional...

China Overseas Land & Investment (SEHK:688) has reported its FY 2025 results with second half revenue of C¥84.9b and basic EPS of C¥0.37, alongside trailing twelve month revenue of C¥168.1b and EPS of C¥1.16 that frame the latest numbers in a broader context. The company has seen half year revenue move from C¥98.2b in 2H 2024 to C¥84.9b in 2H 2025, while basic EPS shifted from C¥0.49 to C¥0.37 over the same periods. Investors will be weighing how these topline and EPS trends feed through to...